Protective effect of HO-1 against oxidative stress in human hepatoma cell line (HepG2) is independent of telomerase enzyme activity

International Journal of Biochemistry and Cell Biology

Volumn 34, Issue 12, 2002, Pages 1619-1628

  Ghattas, Maivel H ^a   Chuang, Linus T ^a   Kappas, Attallah ^b   Abraham, Nader G ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Heme oxygenase; HepG2; Oxidative stress; Telomerase

Indexed keywords

HEME OXYGENASE 1; MESOPORPHYRIN; MESSENGER RNA; OXIDIZING AGENT; HEAT SHOCK PROTEIN; HEME OXYGENASE; HEMIN; PROTECTIVE AGENT; STANNOUS CHLORIDE; TELOMERASE; TIN DERIVATIVE;

ARTICLE; CANCER CELL CULTURE; CATALYSIS; CATALYST; CELL STRAIN HEPG2; CONTROLLED STUDY; ENZYME ACTIVITY; GENE ACTIVITY; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; OXIDATIVE STRESS; PROTEIN EXPRESSION; STRESS; CELL CULTURE; CELL SURVIVAL; DRUG ANTAGONISM; DRUG EFFECT; ENZYME INDUCTION; GENETICS; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL SURVIVAL; ENZYME INDUCTION; HEAT-SHOCK PROTEINS; HEME OXYGENASE (DECYCLIZING); HEMIN; HUMANS; OXIDANTS; OXIDATIVE STRESS; PROTECTIVE AGENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TELOMERASE; TIN COMPOUNDS; TUMOR CELLS, CULTURED;

EID: 0036887571     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(02)00097-3     Document Type: Article

References (55)

1. Greider C., Blackburn E.H. A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature. 337:1989;331-337.
2. Shippen-Lentz D., Blackburn E.H. Functional evidence for an RNA template in telomerase. Science. 247:1990;546-552.
3. Feng J., Funk W.D., Wang S.S., Weinrich S.L., Avilion A.A., Chiu C.P., Adams R.R., Chang E., Allsopp R.C., Yu J. The RNA component of human telomerase. Science. 269:1995;1236-1241.
4. Nakamura T., Morin G.B., Chapman K.B., Weinrich S.L., Andrews W.H., Lingner J., Harley C.B., Cech T.R. Telomerase catalytic subunit homologs from fission yeast and human. Science. 277:1997;955-959.
5. Kyo S., Kanaya T., Takakura M., Tanaka M., Inoue M. Human telomerase reverse transcriptase as a critical determinant of telomerase activity in normal and malignant endometrial tissues. Int. J. Cancer. 80:1999;60-63.
6. Artandi S., DePinho R.A. A critical role for telomeres in suppressing and facilitating carcinogenesis. Curr. Opin. Genet. Dev. 10:2000;39-46.
7. Jobin C., Morteau O., Han D.S., Balfour S.R. Specific NF-κB blockade selectively inhibits tumour necrosis factor-α-induced COX-2 but not constitutive COX-1 gene expression in HT-29 cells. Immunology. 95:1998;537-543.
8. Hiyama E., Hiyama K., Yokoyama T., Matsuura Y., Piatyszek M.A., Shay J.W. Correlating telomerase activity levels with human neuroblastoma outcomes. Nat. Med. 1:1995;249-255.
9. Albanell J., Lonardo F., Rusch V., Engelhardt M., Langenfeld J., Han W., Klimstra D., Venkatraman E., Moore M.A., Dmitrovsky E. High telomerase activity in primary lung cancers: association with increased cell proliferation rates and advanced pathologic stage. J. Natl. Cancer Inst. 89:1997;1609-1615.
10. Tahara H., Kuniyasu H., Yokozaki H., Yasui W., Shay J.W., Ide T., Tahara E. Telomerase activity in pre-neoplastic and neoplastic gastric and colorectal lesions. Clin. Cancer Res. 1:1995;1245-1251.
11. Yoshida K., Sugino T., Tahara H., Woodman A., Bolodeoku J., Nargund V., Fellows G., Goodison S., Tahara E., Tarin D. Telomerase activity in bladder carcinoma and its implication for non-invasive diagnosis by detection of exfoliated cancer cells in urine. Cancer. 79:1997;362-369.
12. Langford L., Piatyszek M.A., Xu R., Schold S.C. Jr., Shay J.W. Telomerase activity in human brain tumours. Lancet. 346:1995;1267-1268.
13. Kishimoto K., Fujimoto J., Takeuchi M., Yamamoto H., Ueki T., Okamoto E. Telomerase activity in hepatocellular carcinoma and adjacent liver tissues. J. Surg. Oncol. 69:1998;119-124.
14. Zhang R., Zhang R.P., Wang X.W., Xie H. Effects of cisplatin on telomerase activity and telomere length in BEL-7404 human hepatoma cells. Cell Res. 12:2002;55-62.
15. von Zglinicki T., Saretzki G., Docke W., Lotze C. Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence? Exp. Cell Res. 220:1995;186-193.
16. Furumoto K., Inoue E., Nagao N., Hiyama E., Miwa N. Age-dependent telomere shortening is slowed down by enrichment of intracellular Vitamin C via suppression of oxidative stress. Life Sci. 63:1998;935-948.
17. Ren J., Xia H.L., Tian Y.M., Just T., Cai G.P., Dai Y.R. Expression of telomerase inhibits hydroxyl radical-induced apoptosis in normal telomerase negative human lung fibroblasts. FEBS Lett. 488:2001;133-138.
18. Maines M. The heme oxygenase system: a regulator of second messenger gases. Ann. Rev. Pharmacol. Toxicol. 37:1997;517-554.
19. Shibahara S., Muller M., Taguchi H. Transcriptional control of rat heme oxygenase by heat shock. J. Biol. Chem. 262:1987;12889-12892.
20. Dwyer B., Nishimura R.N., Lu S.Y., Alcaraz A. Transient induction of heme oxygenase after cortical stab wound injury. Brain Res. Mol. Brain Res. 38:1996;251-259.
21. McCoubrey W. Jr., Huang T.J., Maines M.D. Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur. J. Biochem. 247:1997;725-732.
22. Raju V. Regulation of heme ozygenase-2 by glucocorticoids in neonatal rat brain: characterization of a functional glucocorticoid response element. Biochim. Biophys. Acta. 1351:1997;89-104.
23. Stocker R., Yamamoto Y., McDonagh A.F., Glazer A.N., Ames B.N. Bilirubin is an antioxidant of possible physiological importance. Science (Washington, DC). 235:1987;1043-1047.
24. Dore S., Takahashi M., Ferris C.D., Zakhary R., Hester L.D., Guastella D., Snyder S.H. Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc. Natl. Acad. Sci. U.S.A. 96:1999;2445-2450.
25. Neuzil J., Stocker R. Free and albumin-bound bilirubin are efficient co-antioxidants for α-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J. Biol. Chem. 269:1994;16712-16719.
26. Yang C., Shen H.M., Ong C.N. Protective effect of ebselen against hydrogen peroxide-induced cytotoxicity and DNA damage in HepG2 cells. Biochem. Pharmacol. 57:1999;273-279.
27. Deramaudt B., Braunstein S., Remy P., Abraham N.G. Gene transfer of human heme oxygenase into coronary endothelial cells potentially promotes angiogenesis. J. Cell Biochem. 68:1998;121-127.
28. Schacter B., Kurz P. Alterations in microsomal drug metabolism and heme oxygenase activity in isolated hepatic parenchymal and sinusoidal cells in Murphy-Sturm lymphosarcoma-bearing rats. Clin. Invest. Med. 9:1986;150-155.
29. Lavrovsky Y., Schwartzman M.L., Levere R.D., Kappas A., Abraham N.G. Identification of binding sites for transcription factors NF-κB and AP-2 in the promoter region of the human heme oxygenase-1 gene. Proc. Natl. Acad. Sci. U.S.A. 91:1994;5987-5991.
30. Maines M., Abrahamsson P.A. Expression of heme oxygenase-1 (HSP32) in human prostate: normal, hyperplastic, and tumor tissue distribution. Urology. 47:1996;727-733.
31. Goodman A., Choudhury M., da-Silva J.L., Schwartzman M.L., Abraham N.G. Overexpression of the heme oxygenase gene in renal cell carcinoma. Proc. Soc. Exp. Biol. Med. 214:1997;54-61.
32. Matsumoto A., Hanayama R., Nakamura M., Suzuki K., Fujii J., Tatsumi H., Taniguchi N. A high expression of heme oxygenase-1 in the liver of LEC rats at the stage of hepatoma: the possible implication of induction in uninvolved tissue. Free Radic. Res. 28:1998;383-391.
33. Kappas A., Drummond G.S., Vallaes J. A single dose of Sn-mesoporphyrin prevents development of significant hyperbilirubinemia in glucose-6 phosphate dehydrogenase deficient newborns. Pediatrics. 108:2001;25-30.
34. Abraham N., Lavrovsky Y., Schwartzman M.L., Stoltz R.A., Levere R.D., Gerritsen M.E., Shibahara S., Kappas A. Transfection of the human heme oxygenase gene into rabbit coronary microvessel endothelial cells: protective effect against heme and hemoglobin toxicity. Proc. Natl. Acad. Sci. U.S.A. 92:1995;6798-6802.
35. Abraham N., Lin J.H., Dunn M.W., Schwartzman M.L. Presence of heme oxygenase and NADPH cytochrome P-450 (c) reductase in human corneal epithelium. Invest. Ophthalmol. Vis. Sci. 28:1987;1464-1472.
36. Braunstein S., Deramaudt T., Rosenblum D., Dunn M., Abraham N.G. Heme oxygenase-1 gene expression as a stress index to ocular irritation. Curr. Eye Res. 19:1999;115-122.
37. Yang L., Quan S., Abraham N.G. Retrovirus-mediated HO gene transfer into endothelial cells protects against oxidant-induced injury. Am. J. Physiol. 277:1999;L127-L133.
38. Chernick R., Martasek P., Levere R.D., Margreiter R., Abraham N.G. Sensitivity of human tissue heme oxygenase to a new synthetic metalloporphyrin. Hepatology. 10:1989;365-369.
39. Quan S., Yang L., Abraham N.G., Kappas A. Regulation of human heme oxygenase in endothelial cells by using sense and antisense retroviral constructs. Proc. Natl. Acad. Sci. U.S.A. 98:2001;12203-12208.
40. Kim N., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L., Coviello G.M., Wright W.E., Weinrich S.L., Shay J.W. Specific association of human telomerase activity with immortal cells and cancer. Science. 266:1994;2011-2015.
41. Yan P., Saraga E.P., Bouzourene H., Bosman F.T., Benhattar J. Expression of telomerase genes correlates with telomerase activity in human colorectal carcinogenesis. J. Pathol. 193:2001;21-26.
42. Sabaawy H., Zhang F., Nguyen X., Elhosseiny A., Nasjletti A., Schwartzman M., Dennery P., Kappas A., Abraham N.G. Human heme oxygenase-1 gene transfer lowers blood pressure and promotes growth in spontaneously hypertensive rats. Hypertension. 38:2001;210-215.
43. Otterbein L., Choi A.M. Heme oxygenase: colors of defense against cellular stress. Am. J. Physiol. Lung Cell Mol. Physiol. 279:2000;L1029-L1037.
44. Chen K., Gunter K., Maines M.D. Neurons overexpressing heme oxygenase-1 resist oxidative stress-mediated cell death. J. Neurochem. 75:2000;304-313.
45. Petrache I., Otterbein L.E., Alam J., Wiegand G.W., Choi A.M. Heme oxygenase-1 inhibits TNF-α-induced apoptosis in cultured fibroblasts. Am. J. Physiol. Lung Cell Mol. Physiol. 278:2000;L312-L319.
46. Yachie A., Niida Y., Wada T., Igarashi N., Kaneda H., Toma T., Ohta K., Kasahara Y., Koizumi S. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J. Clin. Invest. 103:1999;129-135.
47. Janssen Y., Van Houten B., Borm P.J., Mossman B.T. Cell and tissue responses to oxidative damage. Lab. Invest. 69:1993;261-274.
48. Witztum J., Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88:1991;1785-1792.
49. Simizu S., Takada M., Umezawa K., Imoto M. Requirement of caspase-3(-like) protease-mediated hydrogen peroxide production for apoptosis induced by various anticancer drugs. J. Biol. Chem. 273:1998;26900-26907.
50. von Zglinicki T., Pilger R., Sitte N. Accumulation of single-strand breaks is the major cause of telomere shortening in human fibroblasts. Free Radic. Biol. Med. 28:2000;64-74.
51. Sumida T., Hamakawa H. Telomerase and oral cancer. Oral Oncol. 37:2001;333-340.
52. Vara E., Arias-Diaz J., Garcia C., Hernandez J., Balibrea J.L. TNF-α-induced inhibition of PC synthesis by human type II pneumocytes is sequentially mediated by PGE2 and NO. Am. J. Physiol. 271:1996;L359-L365.
53. Ren J., Xia H.L., Just T., Dai Y.R. Hydroxyl radical-induced apoptosis in human tumor cells is associated with telomere shortening but not telomerase inhibition and caspase activation. FEBS Lett. 488:2001;123-132.
54. Ulaner G., Hu J.F., Vu T.H., Oruganti H., Giudice L.C., Hoffman A.R. Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endometrium and myometrium. Int. J. Cancer. 85:2000;330-335.
55. de Kok J., Schalken J.A., Aalders T.W., Ruers T.J., Willems H.L., Swinkels D.W. Quantitative measurement of telomerase reverse transcriptase (hTERT) mRNA in urothelial cell carcinomas. Int. J. Cancer. 87:2000;217-220.